Crude and adjusted effectiveness of the 13-valent pneumococcal conjugate vaccination against IPD caused by PCV13 serotypes including and excluding serotype 3 in the prevention of invasive pneumococcal disease in children aged 7–59 months according to vaccination schedule, number of doses received and age.
- Ángela Domínguez (4353922)
- Pilar Ciruela (314318)
- Sergi Hernández (3547127)
- Juan José García-García (4353919)
- Núria Soldevila (2175832)
- Conchita Izquierdo (3547133)
- Fernando Moraga-Llop (4353892)
- Alvaro Díaz (4353910)
- Mariona F. de Sevilla (698457)
- Sebastià González-Peris (4353913)
- Magda Campins (4353901)
- Sonia Uriona (4353904)
- Johanna Martínez-Osorio (4353907)
- Anna Solé-Ribalta (4353895)
- Gemma Codina (4353889)
- Cristina Esteva (2556901)
- Ana María Planes (4353898)
- Carmen Muñoz-Almagro (314323)
- Luis Salleras (4353916)
Publication date
August 2017
DOIAbstract
<p>Crude and adjusted effectiveness of the 13-valent pneumococcal conjugate vaccination against IPD caused by PCV13 serotypes including and excluding serotype 3 in the prevention of invasive pneumococcal disease in children aged 7–59 months according to vaccination schedule, number of doses received and age.</p
Add to ORKG